welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!
recruiting

A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids

key information

study id #: NCT02814019

condition: Duchenne Muscular Dystrophy (DMD)

status: recruiting

purpose:

The purpose of the study is to assess the efficacy of idebenone in delaying the loss of respiratory function in patients with DMD receiving concomitant glucocorticoid steroids

intervention: Idebenone 150 mg film-coated tablets, placebo

mechanism of action: Antioxidant to support health

results: https://clinicaltrials.gov/ct2/show/results/NCT02814019

last updated: December 04, 2019

rareRelated